Accupril is a brand name of quinapril, approved by the FDA in the following formulation(s):
ACCUPRIL (quinapril hydrochloride - tablet; oral)
Manufacturer: PFIZER PHARMS
Approval date: November 19, 1991
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [RLD][AB], EQ 5MG BASE [AB]
Has a generic version of Accupril been approved?
A generic version of Accupril has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Accupril and have been approved by the FDA:
quinapril hydrochloride tablet; oral
Manufacturer: APOTEX
Approval date: January 26, 2006
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: INVAGEN PHARMS
Approval date: August 24, 2007
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: LUPIN
Approval date: June 20, 2006
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: MYLAN
Approval date: December 23, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: MYLAN
Approval date: January 28, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: RANBAXY
Approval date: December 15, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: SANDOZ
Approval date: March 2, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: SUN PHARM INDS LTD
Approval date: June 18, 2009
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: TEVA
Approval date: August 24, 2007
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Manufacturer: WATSON LABS FLORIDA
Approval date: January 14, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB], EQ 5MG BASE [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Accupril. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Method of treating cardiac insufficiency
Patent 5,684,016
Issued: November 4, 1997
Inventor(s): Henning; Rainer & Urbach; Hansjorg & Teetz; Volker & Geiger; Rolf & Scholkens; Bernward
Assignee(s): Hoechst Aktiengesellschaft
The invention relates to a method of treating cardiac insufficiency by using compounds of the formula I ##STR1## in which n is 1 or 2, R, R.sup.1, R.sup.2 and R.sup.3 are identical or different and each denote hydrogen or an organic radical and R.sup.4 and R.sup.5, together with the atoms carrying them, form a mono-, bi- or tri-cyclic heterocyclic ring system. The invention furthermore relates to compounds of the formula I and agents containing these for use in the treatment of the abovementioned disease.Patent expiration dates:
- November 4, 2014✓
- May 4, 2015✓✓
- November 4, 2014
See also...
- Accupril Consumer Information (Drugs.com)
- Accupril Consumer Information (Wolters Kluwer)
- Accupril Consumer Information (Cerner Multum)
- Accupril Advanced Consumer Information (Micromedex)
- Accupril AHFS DI Monographs (ASHP)
- Quinapril Consumer Information (Wolters Kluwer)
- Quinapril Consumer Information (Cerner Multum)
- Quinapril Advanced Consumer Information (Micromedex)
- Quinapril Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment